XML 44 R30.htm IDEA: XBRL DOCUMENT v3.25.2

Note 11 - Segment Information (Tables)

3 Months Ended

Jun. 30, 2025

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Three months ended June 30, 2025		Sterilization and Disinfection Control				Biopharmaceutical Development				Calibration Solutions				Clinical Genomics				Total
Revenues (a):		$	25,410			$	11,486			$	12,350			$	10,297			$	59,543
Less
Depreciation in cost of revenues			450				89				105				166				810
Amortization in cost of revenues			139				372				-				191				702
Other cost of revenues (b)			6,655				4,719				5,203				4,515				21,092
Total segment cost of revenues			7,244				5,180				5,308				4,872				22,604
Gross Profit (c)		$	18,166			$	6,306			$	7,042			$	5,425			$	36,939
Reconciling items:
Operating expense																		$	33,875
Operating income																			3,064
Nonoperating (income), net																			(3,948	)
Earnings before income taxes																		$	7,012

Three months ended June 30, 2024		Sterilization and Disinfection Control				Biopharmaceutical Development				Calibration Solutions				Clinical Genomics				Total
Revenues (a):		$	22,957			$	12,008			$	11,801			$	11,404			$	58,170
Less
Depreciation in cost of revenues			419				46				185				212				862
Amortization in cost of revenues			111				345				-				191				647
Non-cash GKE inventory step-up amortization			778				-				-				-				778
Other cost of revenues (b)			6,091				3,658				4,374				4,511				18,634
Total segment cost of revenues			7,399				4,049				4,559				4,914				20,921
Gross Profit (c)		$	15,558			$	7,959			$	7,242			$	6,490			$	37,249
Reconciling items:
Operating expense																		$	31,669
Operating income																			5,580
Nonoperating expense, net																			1,675
Earnings before income taxes																		$	3,905

Schedule of Segment Reporting Information, by Inventory Segment [Table Text Block]

		June 30,				March 31,
		2025				2025
Sterilization and Disinfection Control		$	6,269			$	5,545
Biopharmaceutical Development			5,944				4,934
Calibration Solutions			5,887				5,110
Clinical Genomics			10,006				9,776
Total inventories		$	28,106			$	25,365

X

- Definition

A table disclosing the inventory totals for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment inventory reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment inventory.

+ References

No definition available.

+ Details

Name:	mlab_ScheduleOfSegmentReportingInformationByInventorySegmentTableTextBlock
Namespace Prefix:	mlab_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_TableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration